Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cancer lesion tissue evaluation for optimizing effect of boron neutron capture therapy

A technology for cancer cells and related factors, which is applied to the active components of boron compounds, biochemical equipment and methods, and disease diagnosis. It can solve problems such as high cost, no effective means found, and limited reagent prices, so as to reduce failure and realize individualization Effects of Medicine, Expansion Potential

Active Publication Date: 2020-11-20
3 D MATRIX
View PDF9 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, predicting the effect is not easy due to the limited facilities available for PET imaging and the high cost of reagents
Additionally, no effective means of assessing the uptake of boron agents other than BPA into cells has been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cancer lesion tissue evaluation for optimizing effect of boron neutron capture therapy
  • Cancer lesion tissue evaluation for optimizing effect of boron neutron capture therapy
  • Cancer lesion tissue evaluation for optimizing effect of boron neutron capture therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0120] Example 1. Uptake of BSH to which a peptide containing a basic amino acid residue is covalently linked, and a complex comprising a peptide containing a basic amino acid residue and BSH, into CD44-expressing and CD44-knockdown cancer cells

[0121]To examine BSH to which a peptide consisting of three arginines was covalently linked (termed BSH-3R), to which a peptide consisting of undecyl-arginines was covalently linked (termed BSH-11R), and The relationship between the intracellular uptake of a complex containing Ala-Ala-Ala-Ala-Ala-Ala-Lys and BSH (termed BSH / A6K) and CD44 expression, first introduced CD44-shRNA lentivirus into The malignant brain tumor cell line U87MG was used to generate CD44 knockdown cell sublines. Knockdown efficiency was confirmed by Western blotting with an anti-CD44 antibody (manufactured by Cell Signaling Technology, Inc.). Then, in order to verify the correlation of the introduction efficiency of BSH-11R and BSH / A6K with the expression level...

Embodiment 2

[0124] Example 2. BSH targeting translation-related factors via covalently linked peptides containing basic amino acid residues

[0125] Simple BSH (referred to as BSH) (50 μM) or BSH-11R (50 μM) was added to the cell disruption solution of the malignant brain tumor cell line U251, and by immunoprecipitation with an anti-BSH antibody (10 μg), the Proteins that bind BSH and BSH-11R.

[0126] The results are shown in figure 2 middle. Since more translation-related factors co-precipitated with BSH-11R compared with BSH, the peptide portion (11R) of BSH-11R was found to be essential for binding to translation-related factors. It was also found that there are mRNA-independent binding modes and mRNA-dependent binding modes according to translation-related factors.

[0127] To examine whether the binding of BSH-11R to translation-related factors is direct or indirect, a subline of the malignant brain tumor cell line U251, which underwent knockdown of translation-related factors w...

Embodiment 3

[0130] Example 3. BNCT using BSH to which a peptide containing basic amino acid residues is covalently linked

[0131] Based on the binding of BSH-11R to translation-related factors, it is thought that the translation machinery can be selectively targeted. Therefore, it was decided to perform BNCT using BSH-11R. The malignant brain tumor cell line U87ΔEGFR was pretreated with 100 μM BSH-11R (24 hours before irradiation). Cells were detached with trypsin on the day of irradiation at 1 x 10 6 Amounts of cells / mL were dispensed into tubes and irradiated with neutron radiation using an accelerator (at the National Institute of Radiological Sciences). Irradiation times were 0, 15, 45, and 60 minutes, and each base Gy (Gray) was estimated and calculated to be less than or equal to 1 Gy.

[0132] The irradiated cells were recovered, RNA extraction was performed, and then an equal amount of RNA (1000 ng) was used as a template to generate cDNA, and quantitative PCR was performed. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method, a kit, etc., for predicting the response of a BNCT using a BSH-related medicine-containing boron preparation and a BPA-containing boron preparation, the method and kit being characterized by examining the expression of CD44, a translation-related factor and / or LAT1 in cancer cells of a sample. When the expression of the CD44 or translation-related factorin the cancer cells of the sample is high, it can be predicted that the BNCT using the BSH-related medicine-containing boron preparation is likely to be responsive. When the expression of the LAT1 inthe cancer cells of the sample is high, it can be predicted that the BNCT using the BPA-containing boron preparation is likely to be responsive.

Description

technical field [0001] The present invention relates to methods and kits for predicting the effect of boron neutron capture therapy (BNCT). Background technique [0002] BNCT is a method of treating cancer by administering an agent containing boron (boron agent) to cancer patients, selectively incorporating boron atoms into cancer cells, and irradiating neutrons to the affected area. In this method, boron atoms in boron reagents capture neutrons and split into alpha particles (helium nuclei) and lithium nuclei. Cancer cells are selectively destroyed by the energy of alpha particles. Currently, p-boronphenylalanine (BPA) is mainly used as a boron reagent in BNCT. However, there are many carcinomas that have not been found to yield sufficient results for BNCT with conventional BPA, or have not been considered good indications for BNCT so far. [0003] To predict the effect of BPA administration, the tissue accumulation of F-BPA has been assessed by PET imaging, taking advan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68A61K33/22C12Q1/02
CPCG01N2333/70585G01N33/574G01N2800/52A61K33/22G01N33/5008G01N33/6893
Inventor 松井秀树藤村笃史
Owner 3 D MATRIX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com